Interim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations

A. Hollebecque, M. Borad, V. Sahai, D. V.T. Catenacci, A. Murphy, G. Vaccaro, A. Paulson, D. Y. Oh, L. Féliz, C. Lihou, H. Zhen, G. K. Abou-Alfa

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)viii258
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this